1887

Abstract

Human papillomaviruses (HPVs) are aetiological agents for genital warts and cervical cancer, the different pathologies of which are dependent on the type of HPV infection. Oncogenic HPV types associated with cancer are carcinogens by virtue of their oncogene products, which target key regulators of cell proliferation and apoptosis. The viral E6 protein from oncogenic HPV types plays a central role in carcinogenesis by exploiting the cellular proteasome degradation pathway in order to mediate the degradation of cellular proteins, most notably the prototype tumour suppressor protein p53. Much less is known about the cellular targets of E6 from the non-oncogenic HPV types associated with genital warts. It is also unclear what factors influence the level and stability of the viral E6 proteins in cells. This report demonstrates that both oncogenic and non-oncogenic HPV E6 proteins (from types 18 and 11, respectively) are ubiquitinated and targeted for degradation by the 26S proteasome. E6 domains required for the induction of p53 or DLG degradation, or E6AP binding, are not involved in proteasome-mediated degradation of HPV-18 E6. These results provide insight into the cellular modulation of E6 protein levels from both high-risk and low-risk HPV types.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19679-0
2004-06-01
2019-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/6/vir851419.html?itemId=/content/journal/jgv/10.1099/vir.0.19679-0&mimeType=html&fmt=ahah

References

  1. Banks, L., Matlashewski, G. & Crawford, L. ( 1986; ). Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159, 529–534.[CrossRef]
    [Google Scholar]
  2. Gardiol, D., Kuhne, C., Glaunsinger, B., Lee, S. & Javier, R. ( 1999; ). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18, 5487–5496.[CrossRef]
    [Google Scholar]
  3. Glausinger, B. A., Lee, S. S., Thomas, M., Banks, L. & Javier, R. ( 2000; ). Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19, 5270–5280.[CrossRef]
    [Google Scholar]
  4. Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C. & Ciechanover, A. ( 1998; ). Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A 95, 8058–8063.[CrossRef]
    [Google Scholar]
  5. Huibregtse, J., Scheffner, M. & Howley, P. ( 1991; ). A cellular protein mediates association of p53 with the E6 oncoprotein of human papilloma types 16 or 18. EMBO J 10, 4129–4135.
    [Google Scholar]
  6. Huibregtse, J., Scheffner, M. & Howley, P. ( 1993; ). Localization of the E6-AP regions that direct human papillomavirus E6 binding, association p53, and ubiquination of associated proteins. Mol Cell Biol 13, 4918–4927.
    [Google Scholar]
  7. Kao, W. A., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M. & Howley, P. M. ( 2000; ). Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol 74, 6408–6417.[CrossRef]
    [Google Scholar]
  8. Kehmeier, E., Rühl, H., Voland, B., Stöppler, M. C., Androphy, E. & Stöppler, H. ( 2002; ). Cellular steady-state levels of “high-risk” but not “low-risk” human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 292, 72–87.
    [Google Scholar]
  9. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T. & Ishibashi, M. ( 1997; ). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94, 11612–11616.[CrossRef]
    [Google Scholar]
  10. Lee, S. S., Weiss, R. & Javier, R. ( 1997; ). Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94, 6670–6675.[CrossRef]
    [Google Scholar]
  11. Lee, S. S., Glausinger, B., Mantovani, F., Banks, L. & Javier, R. T. ( 2000; ). Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 74, 9680–9693.[CrossRef]
    [Google Scholar]
  12. Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C. & Kain, S. R. ( 1998; ). Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 273, 3470–3475.[CrossRef]
    [Google Scholar]
  13. Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H. T., Pelligrini, S., Matlashewski, G. J. & Koromilas, A. E. ( 1999; ). The human papillomavirus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene 18, 5727–5737.[CrossRef]
    [Google Scholar]
  14. Munoz, N., Bosch, X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K., Snijder, P. & Meijer, C. ( 2003; ). Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518–527.[CrossRef]
    [Google Scholar]
  15. Nakagawa, S. & Huibregtse, J. ( 2000; ). Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin ligase. Mol Cell Biol 21, 8244–8253.
    [Google Scholar]
  16. Pickart, C. ( 2001; ). Ubiquitin enters the new millennium – Meeting Review. Mol Cell 8, 499–504.[CrossRef]
    [Google Scholar]
  17. Pim, D. & Banks, L. ( 1999; ). HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18, 7403–7408.[CrossRef]
    [Google Scholar]
  18. Pim, D., Thomas, M., Javier, R., Gardiol, D. & Banks, L. ( 2000; ). HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19, 719–725.[CrossRef]
    [Google Scholar]
  19. Scheffner, M. & Whitaker, N. J. ( 2003; ). Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol 13, 59–67.[CrossRef]
    [Google Scholar]
  20. Scheffner, M., Wernes, B., Huibregtse, J., Levine, A. & Howley, P. ( 1990; ). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136.[CrossRef]
    [Google Scholar]
  21. Storey, A., Pim, D., Murray, A., Osborn, K., Banks, L. & Crawford, L. ( 1988; ). Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 7, 1815–1820.
    [Google Scholar]
  22. Thomas, M. & Banks, L. ( 1998; ). Inhibition of Bak-induced apoptosis by HPV-18E6. Oncogene 17, 2943–2954.[CrossRef]
    [Google Scholar]
  23. Treier, M., Staszewski, L. M. & Bohmann, D. ( 1994; ). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787–798.[CrossRef]
    [Google Scholar]
  24. Werness, B., Levine, A. & Howley, P. ( 1990; ). Association of human papillomavirus types 16 and 18 proteins with p53. Science 248, 76–79.[CrossRef]
    [Google Scholar]
  25. zur Hausen, H. ( 1991; ). Viruses in human cancers. Science 254, 1167–1173.[CrossRef]
    [Google Scholar]
  26. zur Hausen, H. ( 1996; ). Papillomavirus infections – a major cause of human cancers. Biochim Biophys Acta 1288, F55–78.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19679-0
Loading
/content/journal/jgv/10.1099/vir.0.19679-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error